InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: Batermere post# 92846

Sunday, 02/17/2019 12:05:02 PM

Sunday, February 17, 2019 12:05:02 PM

Post# of 108192
My story is much the same as yours though I have far fewer shares. I still felt the sting. I had cautious optimisim which is now very guarded optimisim. Unlike a few, I still have faith in the science, not so much in the management.

Looking at slide #15 on the CP, it appears the combo trial is providing a definate improvement in survival. Granted, it's early and a small number in patients but, if ADXS-PSA could boost efficacy 10% in Keytruda for this indication, it could spark interest from Merck.

I beleive there is a place for Advaxis' products in the treatment of cancer and hope you, I and the rest can be made whole and eventually walk away happy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News